This newfound stability has enabled the identification of specific mRNA markers, such as Fibrinogen Chain A (FGA) mRNA, which has been shown to significantly differentiate HCC from non-cancer controls in plasma cfRNA profiling studies [11]. This evidence concerns the gene FGA and cancer.